Regional Blockade for Knee Prothesis Surgery: Comparison Between Femoral, Sciatic and Adductor Canal Block
Overview
- Phase
- Not Applicable
- Intervention
- Analgesic nerve blockade (Ropivacaine)
- Conditions
- Total Knee Replacement
- Sponsor
- University of Liege
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Pain measurement with numeric pain scale : from 0 to 10 (maximal pain) in rest condition
- Last Updated
- 10 years ago
Overview
Brief Summary
Comparison of the analgesics blocks (femoral, adductor canal and sciatic subgluteal nerve) for total replacement knee surgery.
Detailed Description
Adductor canal block shows a beneficial effect for knee surgery. Mainly because he prevent for muscular weakness; adverse effect meet with femoral block and delaying the early active mobilization. The investigators want to compare the efficacy and safety of this block compared to the femoral and sciatic block.
Investigators
Pierre Goffin
Clinical assistant
University of Liege
Eligibility Criteria
Inclusion Criteria
- •patients scheduled for total knee replacement surgery.
Exclusion Criteria
- •refusal to study,
- •coagulation disorder,
- •infection at the puncture site,
- •preexisting neuropathy,
- •allergy to local anesthetics,
- •renal or hepatocellular insufficiency,
- •context of chronic pain,
- •drugs abuse,
- •pregnant patient.
Arms & Interventions
Femoral nerve blockade
In this group, patient will benefit of an ultrasound guided femoral nerve blockade with continuous catheter infusion as (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for total knee replacement surgery.
Intervention: Analgesic nerve blockade (Ropivacaine)
Femoral nerve blockade
In this group, patient will benefit of an ultrasound guided femoral nerve blockade with continuous catheter infusion as (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for total knee replacement surgery.
Intervention: Total knee replacement surgery.
Adductor canal blockade
In this group, patient will benefit of an ultrasound guided adductor canal blockade with continuous catheter infusion (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for for total knee replacement surgery.
Intervention: Analgesic nerve blockade (Ropivacaine)
Adductor canal blockade
In this group, patient will benefit of an ultrasound guided adductor canal blockade with continuous catheter infusion (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for for total knee replacement surgery.
Intervention: Total knee replacement surgery.
Subgluteal sciatic nerve blockade
In this group, patient will benefit of an ultrasound guided subgluteal sciatic nerve blockade with continuous catheter infusion (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for total knee replacement surgery.
Intervention: Analgesic nerve blockade (Ropivacaine)
Subgluteal sciatic nerve blockade
In this group, patient will benefit of an ultrasound guided subgluteal sciatic nerve blockade with continuous catheter infusion (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for total knee replacement surgery.
Intervention: Total knee replacement surgery.
Outcomes
Primary Outcomes
Pain measurement with numeric pain scale : from 0 to 10 (maximal pain) in rest condition
Time Frame: up to day 7
Pain assessment and evolution in postoperative period (passive condition)
Pain measurement with numeric pain scale (from 0 to 10) during active motorized mobilization (Kinetic)
Time Frame: up to day 7
Pain assessment and evolution in postoperative period (active condition)
Secondary Outcomes
- Opioid consumption(up to 48 hours)
- Patient satisfaction(at day 1)
- Postintervention nausea vomiting(at hour 0, at hours 6, at day 1)